An underlying lesion with malignant or premalignant potential at the base of a cutaneous horn is a common finding wherefore we recommend excision and histology. Malignant tumors Basal cell carcinoma (Syn,: basalioma, basal cell epitelioma) Basal cell carcinoma (BCC) accounts for 90% of all ...
Skin diseases on the nose are seen in a variety of medical disciplines. Dermatologists, otorhinolaryngologists, general practitioners and general plastic and dermatologic surgeons are regularly consulted regarding cutaneous lesions on the nose. This arti
ITH provides a diverse genetic and epigenetic background for selection and cancer evolution. However, CTCL presents as multiple skin lesions at the very early stage of the disease. The manner in which the high transcriptional ITH of CTCL is related to the evolution and spreading of skin lesions ...
Tumors in goats were present on the eye and eyelids, base of the horn, carpus, udder, anus, perineum, vulva, and both anus and vulva. In conclusion, SCC and malignant melanoma were prevalent neoplasms in sheep and goats, respectively. Ocular SCC was frequent in Najdi sheep that have white...
3 1EA2406 Histology and Molecular Pathology of Tumors, University of Bordeaux, Bordeaux, France; 2Dermatology Department, CHU Bordeaux, Bordeaux, France; 3Tumor Bank and Tumor Biology Laboratory, CHU Bordeaux, Bordeaux, France; 4Pathology Department, CHU Bordeaux, Bordeaux, France; 5Dermatology ...
Although the nose has a distinct concave and convex anatomy, pre-operative tumor thickness can be assessed by ultrasound of the skin, depending on the localization of the melanoma [120,121]. In cases of LMM, different techniques of 3D histology have been described. Some authors prefer the Tueb...
(Arafeh et al, 2015;Krauthammer et al, 2015). Furthermore, WES analysis of desmoplastic melanoma, a rare form of melanoma with sarcomatous histology that occur in chronically sun-exposed skin, revealed significant loss-of-function mutations inNF1in over 50% of samples (Shain et al, 2015a)....
Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of non-Hodgkin lymphoma distinguished by the presence of clonal malignant T cells. The heterogeneity of malignant T cells and the complex tumor microenvironment remain poorly characterized